Inhibrx Biosciences, Inc. (INBX) - Dilution Analysis
Visualizing historical and potential share dilution over time
Dilution Analysis
Risk Assessment Details
Summary
INBX currently has 15.6M outstanding shares. with minimal authorized share overhang for future dilution. The company has diluted shareholders by 11.06% over the past 2 years through share issuances.
Share Structure Timeline
Historical Data Points
| Date | Event | Outstanding | Supply |
|---|---|---|---|
| May 14, 2026 |
10-Q filing | 15.6M shares outstanding |
16M | 0 |
| Mar 19, 2026 |
10-K filing | 15.5M shares outstanding |
15M | 0 |
| Aug 13, 2025 |
10-Q filing | 15.5M shares outstanding |
15M | 0 |
| Jun 02, 2025 |
POS AM filing: This POS AM filing relates to an offering of up to 2,449,921 shares of Common Stock by selling stockholders, including shares underlying warrants, with the company not receiving any proceeds from the sale of securities, except for potential proceeds from warrant exercises. |
15M | 0 |
| May 14, 2025 |
10-Q filing | 15.5M shares outstanding |
15M | 0 |
| Apr 17, 2025 |
POS AM filing: This POS AM filing relates to the proposed resale of up to 2,449,921 shares of Inhibrx Biosciences, Inc. common stock by selling stockholders. |
15M | 0 |
| Mar 17, 2025 |
10-K filing | 14.8M shares outstanding |
15M | 2.4M |
| Jan 13, 2025 |
8-K filing: Inhibrx Biosciences, Inc. entered into a Loan and Security Agreement with Oxford Finance LLC, providing for a term loan facility of up to $150.0 million, and issued warrants to purchase 140,741 shares of common stock at an exercise price of $14.21 per share in connection with the initial tranche of funding. |
15M | 2.4M |
| Nov 14, 2024 |
10-Q filing | 15.5M shares outstanding |
15M | 2.4M |
| Aug 13, 2024 |
10-Q filing | 14.6M shares outstanding |
15M | 2.4M |
| Jun 11, 2024 |
S-1 filing: This S-1 filing relates to the proposed resale of up to 2,449,921 shares of common stock by selling stockholders, including shares underlying warrants. |
N/A | 2.4M |
| May 30, 2024 |
8-K filing: Inhibrx Biosciences, Inc. completed the distribution of its common stock to holders of Inhibrx, Inc.'s common stock, issued warrants to purchase up to 991,849 shares of common stock, issued 1,838 shares of common stock to Oxford Finance LLC, filed an Amended & Restated Certificate of Incorporation, and adopted the Amended & Restated Bylaws. |
N/A | 0 |